e.g. mhealth
Search Results (1 to 7 of 7 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 4 JMIR Research Protocols
- 1 JMIR Formative Research
- 1 JMIR Public Health and Surveillance
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

To address this research gap, we propose a proof-of-concept feasibility study (NOVA study) to evaluate the relationship between the levels of serum inflammatory biomarkers and those measured noninvasively in urine, sweat, saliva, exhaled breath, core body temperature, and stool in patients with systemic inflammation.
JMIR Res Protoc 2024;13:e62877
Download Citation: END BibTex RIS

Feasibility was defined by a retention rate (>80%) and adherence rates (>70%) for the assessment measures [18,19], such as survey responses, saliva collections, sweat collection, and HRV sensor wear. Retention was defined as the percentage of participants who completed the baseline survey and completed the 96-hour FTX. The adherence to saliva sampling was defined as the percentage of the collected saliva sample out of a total of 12 collections (4 per day for 3 days).
JMIR Form Res 2024;8:e60925
Download Citation: END BibTex RIS

Research on the detection of other respiratory viruses in saliva [25,26] and previous work by our group with saliva and SARS-Co V-2 [27] piqued our interest in this approach. Although there was no validated technique for using saliva samples at the beginning of this work and serious doubts about its suitability for diagnosing SARS-Co V-2, various studies had postulated saliva as the preferred alternative sample [24,28-31]. Erratic results were observed when comparing saliva and NPSs [24,32-34].
JMIR Public Health Surveill 2024;10:e54503
Download Citation: END BibTex RIS

At the end of this stage, we had a web-based tool that could be used to help with self-assessment of sore throat (and taking throat swabs and saliva samples).
J Med Internet Res 2023;25:e39791
Download Citation: END BibTex RIS

Saliva samples will be collected according to the manufacturer’s instructions. If no specific instruction is provided or for RT-PCR, the sample will be collected by instructing the person being tested to massage the glands on both sides of the jaw and them sampling the saliva produced from the parotid, submandibular, and sublingual glands.
JMIR Res Protoc 2022;11(5):e35706
Download Citation: END BibTex RIS

Interestingly, antibodies are also secreted by mucosal tissues, and SARS-Co V-2–specific antibodies can be detected in saliva and other body fluids [13]. Saliva sampling as a noninvasive method (ie, it does not cause disturbance) for SARS-Co V-2 antibody measurements and is an elegant approach to rapidly assess the prevalence of SARS-Co V-2 infection in vulnerable cohorts at numbers appropriate for epidemiologic investigations [14].
JMIR Res Protoc 2021;10(10):e27739
Download Citation: END BibTex RIS

Part III of the study builds up a liquid biobank from biosamples (blood, urine, stool, saliva) of study part II participants, with samples taken prior to endoscopy. The main objective of study part III is the evaluation of less invasive methods of CRC screening and further characterization of detected neoplasms and defining biomarkers or biomarker panels of different composition (such as proteins, metabolites, DNA, micro RNA, methylation markers) obtained via different -omics platforms.
DARIO study design.
JMIR Res Protoc 2020;9(8):e17516
Download Citation: END BibTex RIS